It is a dark time for science. While neurological journals and researchers rule the MS dialogue, the science of the endothelium, venous function and cerebral blood flow are relegated to "death knells", "closed caskets" and "final words" in neurological publications. Researchers refuse to speak to specialists in other fields. Comments from the scientist who discovered CCSVI are not published. False diagnostic criteria are created. The death knell rings, not for CCSVI, but for the public's' trust.

And yes, there are serious conflicts of interest. Here are Dr. Traboulsee's funding diclosures.
Anthony Traboulsee, MD, has received honoraria from EMD Serono, Teva Neurosciences, Bayer, Biogen Idec, Chugai Pharmaceuticals and Roche. Traboulsee reported relationships with Bayer, Roche, Biogen Idec, Merck Serono, and Chugai.

The most recent negative Canadian CCSVI study, lead by University of British Columbia neurologist Dr. Anthony Traboulsee and published in Th...